FDA Warns Eight CBD Producers to Quit Making Medical Claims

What’s the right revenue per square foot? What’s a realistic business outlook for cultivators? Get realistic market forecasts, state-by-state insights and benchmarks. Get the 2023 Factbook.

A year ago, the U.S. Food and Drug Administration warned six companies to stop making claims about the medicinal benefits of their CBD-based products. Earlier this month, it formally warned another eight.

“Your products are not generally recognized as safe and effective for the above referenced uses,” the FDA wrote to Texas-based Garden Green Gold, referring to several claims on the company’s website about how CBD could help treat everything from schizophrenia to post-traumatic stress disorder.

“Failure to promptly correct these violations may result in legal action,” the letters warned the companies.

The FDA gave all eight companies 15 days to comply with their warning letters, which are dated Feb. 4 and address a total of 22 products. If the firms don’t stop making medicinal claims, the FDA could seize their property and/or get a court injunction to halt sales.

The other firms warned include California-based Cali Stores and Santa Te Premium Oils, Utah-based Dose of Nature and PainBomb, Texas-based Healthy Hemp Oil, Oklahoma-based Morgue Juice, and Michigan Herbal Remedies.

The FDA also ruled last year that CBD products don’t qualify as dietary supplements, thereby leaving them in a legal gray area.